Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD/THC Solution for Fibromyalgia (FibroCann)
NCT05283161Phase 3Unknown
- Sponsor
- Aura Pharma
- Start
- Apr 2022
- Primary completion
- Aug 2022
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of cannabidiol, dronabinol in fibromyalgia (FM), sponsored by Aura Pharma. Status: unknown.
02
Drugs
cannabidioldronabinol
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT05283161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05283161.